POTENTIALS OF SYMPTOMATIC TREATMENT OF ACUTE RESPIRATORY TRACT INFECTIONS IN CHILDREN
https://doi.org/10.15690/vsp.v12i6.878
Abstract
Acute infection of upper respiratory tract is one of the most topical medical and social problems: it is respiratory diseases that cause the majority of children’s and adults’ non-attendance of school lessons and working days. Childhood respiratory infections are characterized by prolonged clinical course. The most common causes of upper respiratory tract infections are viruses, such as rhinovirus, respiratory syncytial virus, influenza and parainfluenza viruses, adeno-, corona- and metapneumoviruses as well as Coxsackie virus and ECHO virus. Antiviral agents are efficient only when administered during first 24–48 hours from the onset of disease, and a number of such drugs have only specific activity, therefore the limitation of possibilities of etiotropic therapy of acute respiratory infections can be established. This often leads to excessive inappropriate usage of antibacterial drugs. Such symptoms as nasal stuffiness and cough which accompany acute respiratory tract infections, can significantly affect patients’ and his family’s quality of life. Symptomatic therapy is traditionally used in order to relieve these symptoms. The article contains data on potentials of one of such symptomatic drugs in treatment of upper respiratory tract infections.
Supporting agencies: Teva, LLC
About the Authors
L. R. Selimzyanova
Scientific Centre of Children Health of RAMS;
I.M. Sechenov First Moscow State Medical University,
Russian Federation
Selimzyanova Liliya Robertovna, Candidate of Medical Science, Senior Research Assistant of the Department of Standardization and Clinical Pharmacology at the FSBI SCCH under the RAMS, Assistant of the Department of Pediatrics and Pediatric Rheumatology at I.M. Sechenov First Moscow State Medical University
Russian Federation
Selimzyanova Liliya Robertovna, Candidate of Medical Science, Senior Research Assistant of the Department of Standardization and Clinical Pharmacology at the FSBI SCCH under the RAMS, Assistant of the Department of Pediatrics and Pediatric Rheumatology at I.M. Sechenov First Moscow State Medical University
E. A. Promyslova
Scientific Centre of Children Health of RAMS, Moscow
Russian Federation
Russian Federation
E. А. Vishneva
Scientific Centre of Children Health of RAMS, Moscow
Russian Federation
Russian Federation
References
1. Gonzales R., Malone D. C., Maselli J. H., Sande M. A. Clin. Infect. Dis. 2001; 33: 757–762.
2. Heikkinen T., Jarvinen A. Lancet. 2003; 361 (9351): 51–59.
3. Bramley T. J., Lerner D., Sames M. J. Occup. Environ. Med. 2002; 44 (9): 822–829.
4. Pappas D. E., Hendley J. O. Pediatr. Rev. 2011; 32 (2): 47–54.
5. Kirkpatrick G. L. Prim. Care. 1996; 23 (4): 657–675.
6. URL: http://www.uptodate.com/contents/the-common-cold-inchildren-clinical-features-and-diagnosis
7. Turner R. B., Weingand K. W., Yeh C. H., Leedy D. W. Clin. Infect. Dis. 1998; 26 (4): 840–846.
8. Noah T. L., Becker S. Am. J. Physiol. 1993; 265 (5 Pt. 1): 472–478.
9. Noah T. L., Henderson F. W., Wortman I. A., Devlin R. B., Handy J., Koren H. S., Becker S. J. Infect. Dis. 1995; 171 (3): 584–592.
10. Naclerio R. M., Proud D., Lichtenstein L. M., Kagey-Sobotka A., Hend ley J. O., Sorrentino J., Gwaltney J. M. J. Infect. Dis. 1988; 157 (1): 133–142.
11. Naclerio R. M., Proud D., Kagey-Sobotka A., Lichtenstein L. M., Hendley J. O., Gwaltney J. M., Jr. Pediatr. Infect. Dis. J. 1988; 7 (3): 218–222.
12. Winther B., Brofeldt S., Gronborg H., Mygind N., Pedersen M., Vejlsgaard R. Acta Otolaryngol. 1984 Sep-Oct; 98 (3–4): 315–20.
13. Revai K., Dobbs L. A., Nair S., Patel J. A., Grady J. J., Chonmaitree T. Pediatrics. 2007; 119 (6): 1408–1412.
14. Likhoradochnye sindromy u detei. Rekomendatsii po diagnostike i lecheniyu. Pod obshch. red. A. A. Baranova, V. K. Tatochenko, M. D. Bakradze [Feverish Syndromes in Children. Recommendations on Diagnosis and Treatment. Edited by A. A. Baranov, V. K. Tatochenko, M. D. Bakradze]. Moscow, Soyuz pediatrov Rossii, 2011. 228 p.
15. Pappas D. E., Hendley J. O., Hayden F. G., Winther B. Pediatr. Infect. Dis. J. 2008; 27 (1): 8–11.
16. Kelly L. F. Pediatr. Rev. 2004; 25 (4): 115–123.
17. Shields M. D., Bush A., Everard M. L., McKenzie S., Primhak R. Thorax. 2008; 63: 1–15.
18. Nisevich L. L., Namazova L. S., Volkov K. S., Vazhnova I. M., Botvinyeva V. V., Zubkova I. V., Filyanskaya E. G. Pediatricheskaya Farmakologiya — Pediatric Pharmacology. 2008; 5 (3): 64–71.
19. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A. D. BMJ. 2010; 340: 2096.
20. Lee G. M., Friedman J. F., Ross-Degnan D. et al. Misconceptions about colds and predictors of health service utilization. Pediatrics. 2003; 111: 231.
21. Brook I., Foote P. A., Hausfeld J. N. J. Med. Microbiol. 2008; 57 (Pt. 8): 1015–1017.
22. Risnes K. R., Belanger K., Murk W., Bracken M. B. Am. J. Epidemiol. 2011; 173 (3): 310–318.
23. Dawson K. P., Abbott G. D., Allan J. New Zealand Med. J. 1983; 96 (734): 481–482.
24. Nurmukhametov R. A. Consilium provisorum. 2001; 1 (1): 21–23.
25. Pritchard S., Glover M., Guthrie G., Brum J., Ramsey D., Kap pler G., Thomas P., Stuart S., Hull D., Gowland P. Pulm. Pharmacol. Ther. 2013; 1094–5539 (13): 00167–00173.
26. Selimzyanova L. R., Promyslova E. A., Vishnyova E. A. Pediatriches kaya Farmakologiya — Pediatric Pharmacology. 2013; 10 (4): 128–130.
27. Baranov A. A., Namazova L. S. Pediatricheskaya Farmakologiya — Pediatric Pharmacology. 2007; 4 (1): 37–41.
28. McKemy D. D., Neuhausser W. M., Julius D. Nature. 2002; 416 (6876): 52–58.
29. Patel T., Ishiuji Y., Yosipovitch G. J. Am. Acad. Dermatol. 2007; 57 (5): 873–878.
30. Berger H., Jarosch E., Madreiter H. J. Int. Med. Res. 1978; 6 (6): 483–486.
31. Berger H., Madreiter H., Jarosch E. J. Int. Med. Res. 1978; 6 (6): 491–493.
32. Monografii VOZ o lekarstvennykh rasteniyakh, shiroko ispolzuyemykh v novykh nezavisimykh gosudarstvakh (NNG) [WHO monographs on medicinal plants commonly used in the Newly Independent States]. Geneva, WHO Publ., 453 p.
33. WHO monographs on selected medical plants. Vol. 2. Geneva: WHO. 2002. 351 p.
34. Paul I. M., Beiler J. S., King T. S., Clapp E. R., Vallati J., Berlin C. M., Jr. Pediatrics. 2010; 126 (6): 1092–1029.
Review
For citations:
Selimzyanova L.R., Promyslova E.A., Vishneva E.А. POTENTIALS OF SYMPTOMATIC TREATMENT OF ACUTE RESPIRATORY TRACT INFECTIONS IN CHILDREN. Current Pediatrics. 2013;12(6):78-81. (In Russ.) https://doi.org/10.15690/vsp.v12i6.878
Views:
817
Email this article 
